BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30648929)

  • 1. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
    Nikiforova MN; Nikitski AV; Panebianco F; Kaya C; Yip L; Williams M; Chiosea SI; Seethala RR; Roy S; Condello V; Santana-Santos L; Wald AI; Carty SE; Ferris RL; El-Naggar AK; Nikiforov YE
    Thyroid; 2019 Feb; 29(2):161-173. PubMed ID: 30648929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid.
    Marchiò C; Da Cruz Paula A; Gularte-Merida R; Basili T; Brandes A; da Silva EM; Silveira C; Ferrando L; Metovic J; Maletta F; Annaratone L; Pareja F; Rubin BP; Hoschar AP; De Rosa G; La Rosa S; Bongiovanni M; Purgina B; Piana S; Volante M; Weigelt B; Reis-Filho JS; Papotti M
    Mod Pathol; 2019 Dec; 32(12):1734-1743. PubMed ID: 31273314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor.
    Nikiforova MN; Nikiforov YE; Ohori NP
    Cancer Cytopathol; 2019 Sep; 127(9):560-566. PubMed ID: 31373774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene of the month:
    Pinto K; Chetty R
    J Clin Pathol; 2020 Sep; 73(9):527-530. PubMed ID: 32699115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of hyalinizing trabecular tumor of the thyroid: diagnostic significance of PAX8-GLIS3 fusion.
    Hayashi S; Bandoh N; Baba S; Hayashi M; Goto T; Takahara M; Kato Y; Aimono E; Nishihara H
    Thyroid Res; 2024 May; 17(1):9. PubMed ID: 38705974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual papillary thyroid carcinoma with hyalinizing trabecular tumor-like feature in a young female patient: a case report.
    Umekita Y; Umeki K; Kawano F; Tanaka H; Kataoka H
    J Med Case Rep; 2023 Mar; 17(1):112. PubMed ID: 36973752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Basili T; Dopeso H; Kim SH; Ferrando L; Pareja F; Da Cruz Paula A; da Silva EM; Stylianou A; Maroldi A; Marchiò C; Rubin BP; Papotti M; Weigelt B; Moreira Ferreira CG; Lapa E Silva JR; Reis-Filho JS
    Int J Cancer; 2020 Oct; 147(8):2253-2264. PubMed ID: 32383186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding and Overcoming the Pitfalls in Cytopathological Diagnosis of Hyalinizing Trabecular Tumor of Thyroid.
    Mahjabin F; Gonsalves C; Drew PA; Mukhtar F; Leon ME
    Int J Surg Pathol; 2024 Feb; 32(1):91-96. PubMed ID: 37050854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ultrasonography features of hyalinizing trabecular tumor of the thyroid are more consistent with its benign behavior than cytology or frozen section readings.
    Lee S; Han BK; Ko EY; Oh YL; Choe JH; Shin JH
    Thyroid; 2011 Mar; 21(3):253-9. PubMed ID: 21190434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A large series of hyalinizing trabecular tumors: Cytomorphology and ancillary techniques on fine needle aspiration.
    Dell'Aquila M; Gravina C; Cocomazzi A; Capodimonti S; Musarra T; Sfregola S; Fiorentino V; Revelli L; Martini M; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
    Cancer Cytopathol; 2019 Jun; 127(6):390-398. PubMed ID: 31135104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hyalinizing trabecular thyroid adenoma: a novel thyroid tumor with diagnostic pitfalls of hyalinizing trabecular adenoma and medullary thyroid carcinoma.
    Hirokawa M; Matsuse M; Mitsutake N; Suzuki A; Higuchi M; Hayashi T; Kamma H; Miyauchi A; Akamizu T
    Diagn Pathol; 2023 Jun; 18(1):74. PubMed ID: 37340328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyalinizing trabecular tumour of the thyroid: fine-needle aspiration cytological diagnosis and correlation with histology.
    Saglietti C; Piana S; La Rosa S; Bongiovanni M
    J Clin Pathol; 2017 Aug; 70(8):641-647. PubMed ID: 28424236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.
    Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M
    Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
    Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphological traits of fine-needle aspirates of hyalinizing trabecular tumor of the thyroid gland: A brief report.
    Wang F; Liu Y
    Indian J Pathol Microbiol; 2024; 67(1):128-132. PubMed ID: 38358201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET/PTC activation in hyalinizing trabecular tumors of the thyroid.
    Papotti M; Volante M; Giuliano A; Fassina A; Fusco A; Bussolati G; Santoro M; Chiappetta G
    Am J Surg Pathol; 2000 Dec; 24(12):1615-21. PubMed ID: 11117781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.
    Armstrong MJ; Yang H; Yip L; Ohori NP; McCoy KL; Stang MT; Hodak SP; Nikiforova MN; Carty SE; Nikiforov YE
    Thyroid; 2014 Sep; 24(9):1369-74. PubMed ID: 24798894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyalinizing trabecular tumour of the thyroid-differential expression of distinct miRNAs compared with papillary thyroid carcinoma.
    Sheu SY; Vogel E; Worm K; Grabellus F; Schwertheim S; Schmid KW
    Histopathology; 2010 Apr; 56(5):632-40. PubMed ID: 20459574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
    Zhang Y; Li F; Chen J
    Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.